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Background: Many HIV/AIDS patients experience pain often due to advanced HIV/AIDS infection and side effects
of treatment. In sub-Saharan Africa, pain management for people with HIV/AIDS is suboptimal. With survival
extended as a direct consequence of improved access to antiretroviral therapy, the prevalence of HIV/AIDS related
pain is increasing. As most care is provided at home, the management of pain requires patient and family
involvement. Pain education is an important aspect in the management of pain in HIV/AIDS patients. Studies of the
effectiveness of pain education interventions for people with HIV/AIDS have been conducted almost exclusively in
western countries.
Methods/design: A randomised controlled trial is being conducted at the HIV and palliative care clinics of two
public hospitals in Malawi. To be eligible, patient participants must have a diagnosis of HIV/AIDS (stage III or IV).
Carer participants must be the individual most involved in the patient’s unpaid care. Eligible participants are
randomised to either: (1) a 30-minute face-to-face educational intervention covering pain assessment and
management, augmented by a leaflet and follow-up telephone call at two weeks; or (2) usual care. Those allocated
to the usual care group receive the educational intervention after follow-up assessments have been conducted
(wait-list control group). The primary outcome is pain severity measured by the Brief Pain Inventory. Secondary
outcomes are pain interference, patient knowledge of pain management, patient quality of life, carer knowledge of
pain management, caregiver motivation and carer quality of life. Follow-up assessments are conducted eight weeks
after randomisation by palliative care nurses blind to allocation.
Discussion: This randomised controlled trial conducted in sub-Saharan Africa among people living with HIV/AIDS
and their carers will assess whether a pain education intervention is effective in reducing pain and improving pain
management, quality of life and carer motivation.
Trial registration: Current Controlled Trials ISRCTN72861423.
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It is estimated that 34 million people were living with
HIV/AIDS at the end of 2010 [1]. In 2010, there were
1.8 million deaths from AIDS, and 2.7 million people
newly infected globally. In the same year, 1.4 million
people commenced HIV medication, an increase of 27%
in the number of people receiving treatment from the
previous year. Greater access to effective treatment has
led to a 19% decline in deaths among people living with
HIV/AIDS between 2004 and 2009.
Sub-Saharan Africa has 10% of the world’s popula-
tion, but it is home to 67% of all people living with
HIV/AIDS, making it the region worst-affected by
HIV/AIDS [1,2]. Antiretroviral therapy can dramatic-
ally increase survival and years of healthy life, but is
unavailable in some parts of the region [2]. In 2009
in sub-Saharan Africa, 37% of the population eligible for
HIV medication were treated, compared with 2% seven
years earlier [3].
In Malawi the prevalence of HIV/AIDS is estimated at
11% of the population aged between 15 and 49 years,
with around 920,000 people living with HIV/AIDS at the
end of 2010 [1,2]. Approximately 250 people are newly
infected each day, and at least 70% of Malawi's hospital
beds are occupied by HIV/AIDS patients, making Malawi
the 12th worst-affected country with HIV/AIDS worldwide
[4]. Substantial progress has been made in the provision of
HIV medication. By the end of 2010, an estimated 250,000
people had commenced HIV treatment representing 52%
of those in need [1]. However, due to inequities within
Malawi’s health system, access to HIV medication is sub-
optimal [5-8]. One initiative to help deal with the challenge
of accessing HIV medication has been the involvement of
nurses in the prescription and administration of medica-
tions. Trained health assistants now provide HIV counsel-
ling services to patients, and this has resulted in a greater
proportion of patients starting HIV medication within
three weeks of diagnosis [1].
Advanced HIV disease infection and its treatment with
HIV medication are associated with physical and psy-
chological symptoms. These require focused assessment
and management using locally available resources and
interventions to optimise quality of life for patients and
their carers [9]. The negative impact of pain on quality
of life has been documented in many studies [10,11].
Pain is a major problem for people living with HIV/
AIDS [12-14]. Pain is the most frequent and main cause
of psychological distress [15,16]. Experiencing pain can
reduce adherence to drugs and quality of life for HIV/
AIDS patients [17-21].
Inadequate pain control remains a challenge for HIV/
AIDS patients and has an impact on their quality of life
[19,20]. Pain is experienced throughout the disease
trajectory, severity being associated with later WorldHealth Organisation (WHO) clinical stage, [22-24] with
an estimated 80% of people with advanced HIV infection
experiencing severe pain [25]. Pain is also experienced
due to the effects of HIV medication [26,27]. With ad-
vances being made in improving access to HIV drugs in
resource poor countries, HIV patients are living longer,
and, therefore, experiencing pain over a longer period
[28,29]. For cost-related reasons there is rarely the op-
portunity for second-line antiretroviral medication to
be prescribed when first-line antiretroviral therapy is
poorly tolerated [30]. There is a need to provide effective
interventions to HIV/AIDS patients in alleviating and
managing pain. Previous trials conducted in western
countries of interventions to improve medication adher-
ence have produced conflicting results; one found evi-
dence that medication adherence and knowledge can be
improved [31] and another suggested that quality of life
outcomes were worse in the intervention group [32]. In a
trial of a symptom management manual for people with
HIV/AIDS, symptom frequency was reduced but only a
small number of trial centres were in sub-Saharan Africa
[9]. The majority of centres were in the United States
where the healthcare context is very different. None of
these trials directly involved unpaid carers, a group likely
to play a key role in the management of pain of those for
whom they care.
Aim
The aim of this trial is to evaluate the effect of an educa-
tional intervention for patients with HIV/AIDS and their
carers. The study will test the following hypotheses:
1. Compared with usual care, patients with HIV/AIDS
who receive a pain education intervention will
report less severity of pain.
2. Compared with usual care, patients with HIV/
AIDS who receive a pain education intervention
will report less interference of pain in their daily
activities.
3. Compared with usual care, patients with HIV/
AIDS who receive a pain education intervention
will have a greater knowledge of pain
management.
4. Compared with usual care, patients with HIV/AIDS
who receive a pain education intervention will have
a better quality of life.
5. Compared with usual care, carers of patients
with HIV/AIDS who receive the pain education
intervention will have greater knowledge of pain
management.
6. Compared with usual care, carers of patients with
HIV/AIDS who receive the pain education
intervention will have greater motivation to
provide care.
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HIV/AIDS who receive the pain education
intervention will have a better quality of life.
Methods/design
Overview of study design
The study is a two-centre randomised wait-list con-
trolled trial. Participants (patients with HIV/AIDS and
their carers) randomly allocated to a pain education
intervention group receive a leaflet-based educational
intervention and verbal instructions for approximately
30 minutes on pain assessment and management in
addition to usual care. Participants randomly allocated
to the usual care group receive standard care, but re-
ceive the leaflet-based educational intervention on
completion of follow-up measures for both treatment
groups (wait-list control). Participants are assessed at
baseline after providing informed consent and then
randomly allocated to either the pain education inter-
vention or usual care arm of the trial. Follow-up as-
sessments are conducted after eight weeks.
Setting
The trial setting is that of HIV and palliative care
clinics within two public hospitals in northern Malawi.
Both hospitals (Ekwendeni and Mzuzu Central) pro-
vide in-patient, clinic-based and home-based care for
people with HIV/AIDS that includes active treatment
and palliative care. Ekwendeni Hospital provides ser-
vices funded by the government. It was one of the
first hospitals in Malawi to provide free HIV/AIDS
medication. Mzuzu Central Hospital is government-
funded and the largest referral hospital in north Malawi
for people with HIV/AIDS. The population served by
these hospitals includes people from both rural and
urban areas.
Study participants
Participants are people living with HIV/AIDS and their
carers. All participants need to be able to read and write
in English or Tumbuka (the vernacular language used in
the northern part of Malawi). They must be adults aged
18 years or over.
Inclusion criteria for people living with HIV/AIDS
To be eligible for the trial, participants must have
received a diagnosis of HIV/AIDS. Participants with
other conditions, such as cancer and tuberculosis, are
included if these conditions present alongside a diag-
nosis of HIV/AIDS. Eligible participants with HIV/
AIDS must be at WHO clinical stages III or IV of
HIV/AIDS, or with a CD4 cell count of less than 350
cells, when the presence of pain and other symptoms
are more likely due to opportunistic infections or sideeffects of HIV treatment. Staging for trial eligibility
is assessed from the medical records if recorded or
through assessment by clinic staff if this information
is not available.
Inclusion criteria for carers
To be eligible for inclusion, carers must be living with
the person with HIV/AIDS and be identified as the indi-
vidual most involved in their care.
Exclusion criteria for people living with HIV/AIDS
People living with HIV/AIDS will be excluded if they have
health problems that may hinder cognition and communi-
cation, such as HIV-associated dementia. This is assessed
by the attending clinical officer during history-taking at the
initial assessment or at clinic review.
Recruitment
People living with HIV/AIDS in Malawi typically visit
the hospital (palliative care clinics and HIV clinics) with
their family members. Posters about the study entitled
‘Pain Education Study’ are prominently displayed and
potential participants have the opportunity to be given
further information about the study directly from KN or
from clinic staff.
The study is introduced either during the first appoint-
ment at the HIV clinic for newly registered patients or
during routine appointments at the HIV clinics or pallia-
tive care clinics for those who are already receiving HIV
medication (see Figure 1). KN or the staff in these clinics
inform patients about the study and provide them with
information sheets. Potential participants are encouraged
by KN or the clinic staff to discuss with family members
before making a decision to take part.
Potential participants have between two and four
weeks to consider taking part in the study. During their
next appointment those who are interested in taking
part in the study are asked to provide written informed
consent by KN. A checklist is administered to confirm
that all criteria for study eligibility are met.
Randomisation
After baseline assessments, participants are randomly allo-
cated to the pain education intervention group or usual
care group. Randomisation is implemented by KN using
opaque, sealed and numbered envelopes. The envelope is
opened in the presence of the participants after baseline as-
sessments. Participants have a 50% chance of being allo-
cated to either the pain education intervention group or
usual care group. In order to limit imbalance between the
treatment groups, participants are randomly assigned with
block randomisation using the ‘ralloc’ command in Stata
version 12 [33] Name of manufacturer: StataCorp, College






Figure 1 Flow diagram of study design.
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of the envelopes and is blind to block size.
Interventions
Usual care
Assistance with pain management for patients with
HIV/AIDS is currently provided by hospital-based pallia-
tive care nurses and typically delivered in either a pallia-
tive care clinic or HIV clinic. Information relating to
pain medication is typically responsive rather than pro-
active and ad hoc rather than systematic. Information is
provided when requested by patients or carers. The
focus is mostly restricted to pharmacological treatment
of pain. Pain assessments are not usually conducted in asystematic way and not recorded routinely. It is unusual
for this information to be shared with patients and/or
their carers.
Pain education intervention
The pain education intervention is informed by a
biopsychosocial approach [34] to management of pain
among people with HIV/AIDS. This conceptual frame-
work has guided the development of the intervention
in targeting adequate and effective use of analgesia
(biological), providing support and knowledge to min-
imise distress associated with poorly controlled pain
(psychological), and targeting the intervention at the
level of the patient/carer dyad (social). The
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session delivered face-to-face by KN to the participants
at the HIV clinic or palliative care clinic. The face-to-
face session takes approximately 30 minutes wherein
KN explains the intervention to the patient and carer
and both are given a copy of the leaflet and allowed to
browse through it briefly. KN then discusses the con-
tents of the leaflet with the participants and they are
both encouraged to ask questions. After two weeks,
participants receive a phone call reminder to enquire
whether they have any further questions after reading




After recruitment and obtaining written consent from par-
ticipants, but prior to randomisation, baseline assessments
are conducted by KN. Baseline assessments include rele-
vant details from medical notes (date of diagnosis, currentTable 1 Components of the pain education intervention
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Possible cause
Characteristics
Beliefs and myths about pain in HIV/AIDS Participants gi
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Beliefs and myths about pain medication Ask the partic
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Pharmacological management of pain Demonstrate,
Give examples
Discuss most
Non-pharmacological management of pain Identify what
Practical demo
Other items to be covered Participants gi
Participants en
and refer to it
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a missed call t
Routine followtreatments) and demographics. Other measures taken at
baseline are those used as outcomes for the trial.
The primary outcome is pain severity measured using
the Brief Pain Inventory [35]. A range of secondary out-
comes have been chosen due to the complex nature of
the intervention. The time point between delivery of the
intervention and follow-up assessments was chosen to be
consistent with other studies of pain education [36,37].
Patients are assessed in terms of pain severity, pain inter-
ference with daily activities, knowledge of pain manage-
ment, and quality of life. Carers are assessed in terms of
knowledge of pain management, caregiver motivation
and quality of life. These are measured as follows:
1. Pain severity is measured using the single item of
the Brief Pain Inventory (BPI-PS) [35] where
patients are asked to rate the severity of their pain
on average over the last week. A rating is made on a
0 to 10 point scale with higher scores indicating
greater severity of pain. This is consistent with theatient and carer) welcomed
and clarifications as required
ed and participants given time to read through
n relation to HIV/AIDS
s of pain in HIV/AIDS discussed
of pain relating to HIV/AIDS
ven opportunity to share beliefs about pain in relation to HIV/AIDS
riate misconceptions dispelled
ipants’ beliefs about use of pain medication
d dispel misconceptions as required about pain medication
with the help of body diagrams how to locate and describe pain
use of pain assessment tools to rate and record pain
with pain diagrams how to classify pain
f pain experienced and strategies used to manage pain
in which pain may be managed more effectively
using the WHO analgesic ladder, how pain is managed with medications
of available drugs used on the WHO ladder
effective timing of pain medication
non-pharmacological interventions participants are aware of and use
nstrations on use of non-pharmacological interventions as appropriate
ven further opportunity to clarify any of the points discussed
couraged to re-read the leaflet after the end of the face-to-face meeting
whenever the patient experiences pain
ants to ask for clarification about the leaflet and its contents by sending
o KN who will then return the call
-up call at two weeks
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trials [38]. The BPI has been used with patients with
cancer and other chronic illnesses such as HIV/
AIDS [15,39] and to study the management of pain
in South Africa [40].
2. Pain interference with daily activities is measured
using the mean score of the seven pain interference
items of the Brief Pain Inventory (BPI-PI). These
items measure, on a scale of 0 to 10, the degree to
which the patient reports pain interfering with each
of seven activities (general activity, walking, work,
mood, enjoyment of life, relations with others and
sleep) and is the recommended method of
assessment of pain-related functional impairment in
clinical trials [41].
3. For patients, knowledge of pain management is
measured using the knowledge subscale of the
Patient Pain Questionnaire (PPQ-K) [42]. The
PPQ-K is made up of nine items asking the patient to
disagree or agree with statements about the
effectiveness, timing of pain medication dosage, and
adequacy of pain medication dosage. Agreement/
disagreement is rated on a scale of 0 to 10. Scores
range from 0 to 90 with higher scores indicating
greater patient knowledge of pain management.
4. For patients, quality of life is measured using the
APCA African POS [43]. The APCA African POS
consists of seven items directed at patients
addressing pain and symptom assessment,
psychological and emotional concerns. Possible
scores range from 0 to 35 with higher scores
indicating worse outcomes/quality of life. The tool
has been developed and tested in three African
countries [44].
5. For carers, knowledge of pain management is
measured using the knowledge subscale of the
Family Pain Questionnaire (FPQ-K) [45]. Like the
PPQ-K, the FPQ-K is made up of nine items asking
the carer to disagree or agree with statements about
the effectiveness, timing of pain medication dosage,
and adequacy of pain medication dosage. Agreement/
disagreement is rated on a scale of 0 to 10. Scores
range from 0 to 90 with higher scores indicating
greater carer knowledge of pain management.
6. Carer motivation is measured using the Picot
Caregiver Rewards Scale (PCRS) [46]. The PCRS is a
16-item scale measuring the positive consequences
of caregiving. Respondents rate the degree to which
items describe positive consequences of their
caregiving on a 5-point Likert scale. Possible scores
range from 0 to 64 with higher scores indicating
more positive caregiving experience.
7. For carers, quality of life is measured using the
APCA African POS [43]. The APCA African POSconsists of three items directed at carers addressing
the adequacy of information the family has received,
confidence in caring, and level of worry. Possible
scores range from 0 to 15 with higher scores
indicating worse outcomes/quality of life.
While the BPI [40] and APCA African POS [43] have
both been used previously in Sub-Saharan African Popula-
tions, use of the PPQ, FPQ and PCRS has been restricted
to populations in western countries. Our experience imme-
diately prior to trial recruitment of piloting these scales as
part of the questionnaires among 10 patients and 10 carers
suggests that they are acceptable to and understood by
members of the population of patients and carers from
which our sample is being recruited.
Follow-up
Follow-up measures are conducted after eight weeks fol-
lowing delivery of the intervention. Nurses blind to treat-
ment group conduct the follow-up assessments. This is
implemented during the routine appointments to the HIV
or palliative care clinic.
Sample size
We wish to be able to detect a mean difference of 10%
between the treatment groups in the primary outcome
measure (average pain severity in the BPI). A 10% im-
provement is the lower limit of changes considered clin-
ically important [47]. Using a P-value cut-off of 0.05 to
determine a statistically significant result, 76 people per
arm of the trial will be needed to complete the study to
give 80% power to detect such a difference. This is based
on a review [48] that suggests that education-based in-
terventions are able to produce this level of improve-
ment in pain reduction, and that a standard deviation of
2.2 points is a liberal estimate of variability. To allow for
15% attrition, we will attempt to recruit 180 participants
to the trial.
Statistical analysis
We will provide a descriptive account of the two treat-
ment groups at baseline in terms of demographics,
recruiting centre, stage of HIV/AIDS and baseline values
of all study outcomes. All patients and carers will be
analysed according to the group to which they were
randomised. Treatment groups will be compared in
terms of our primary outcome measure (pain severity
using the BPI-PS treated as a continuous measure) using
a linear regression model with baseline BPI and treat-
ment group and recruiting centre as covariates. Analysis
of each of the six secondary outcomes (BPI-PI, PPQ-K,
APCA African POS patient score, FPQ-K, PCRS, APCA
African POS carer score) will be conducted using six
equivalent models with estimates of treatment effect
Nkhoma et al. Trials 2013, 14:216 Page 7 of 8
http://www.trialsjournal.com/content/14/1/216conditional on the value of the outcome at baseline. Sen-
sitivity analysis will be reported and performed as fol-
lows: we will conduct secondary analyses that (1) adjust
for variables that are potential predictors of outcome
(for example, age, gender, stage of HIV/AIDS, medi-
cation use at baseline) and (2) make worst-case and best-
case scenario assumptions about participants lost to
follow-up using the Stata command ‘rctmiss’ [49]. Ana-
lysis will be conducted using Stata version 12 [33].
Ethical approval
The study has been approved by the University of
Nottingham Medical School Research Ethics Committee
(SNMP 11042012) and National Health Sciences Research
Committee of Malawi (NHSRC 1023).
Discussion
Findings from this trial will inform the management
of pain experienced by people living with HIV/AIDS.
Previous trials of interventions designed to enhance
self-management for people living with HIV/AIDS have
been conducted either exclusively [31,32,50] or predom-
inantly [9] in western countries. Differences in terms of
culture and healthcare systems mean it is unwise to un-
critically apply evidence for non-pharmacological inter-
ventions from resource rich countries to those that are
resource poor. Our trial also differs from these studies in
intervening at the level of the patient/carer dyad. Family
carers are a crucial component in the delivery of care for
people living with HIV/AIDS in Malawi and other similar
African countries. Most pain management educational
intervention studies have been conducted in cancer pop-
ulations [36,51-53]. Our intervention is targeted at pain
experienced by people living with HIV/AIDS. The inter-
vention is simple and fits within a model of care where
most healthcare contact is between patients and nurses
and is supported by trained health assistants.
Trial status
The trial commenced recruiting in September 2012. We
anticipate reaching our recruitment target by June 2013.
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